SUBCUTANEOUS TUMOR

Clinical trials for SUBCUTANEOUS TUMOR explained in plain language.

Never miss a new study

Get alerted when new SUBCUTANEOUS TUMOR trials appear

Sign up with your email to follow new studies for SUBCUTANEOUS TUMOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

First human test of new Tumor-Injected therapy for tough cancers

Disease control Recruiting now

This is an early-stage safety study for a new drug called ANK-101, which is injected directly into tumors. It aims to find a safe dose for people with advanced solid cancers that have stopped responding to standard treatments. The study will test the drug alone in different types…

Matched conditions: SUBCUTANEOUS TUMOR

Phase: PHASE1 • Sponsor: Ankyra Therapeutics, Inc • Aim: Disease control

Last updated Mar 27, 2026 12:38 UTC

SUBCUTANEOUS TUMOR

Get alerted when new SUBCUTANEOUS TUMOR trials appear

First human test of new Tumor-Injected therapy for tough cancers